Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder
Conditions: Agitation Associated With Schizophrenia or Bipolar Disorder; Bipolar Disorder; Schizophrenia; Agitation,Psychomotor Intervention: Drug: Sublingual film containing Igalmi Sponsors: BioXcel Therapeutics Inc; Lotus Clinical Research, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Antipsychotic Induced Hyperprolactinemaia as Risk Factor for Periodontitis in Schizophrenic Patients
Conditions: Schizophrenia Spectrum and Other Psychotic Disorders; Periodontal Diseases Intervention: Drug: antipsychotic drugs inducing hyperprolactinemia Sponsor: Fayoum University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder
Conditions: Agitation Associated With Schizophrenia or Bipolar Disorder; Bipolar Disorder; Schizophrenia; Agitation,Psychomotor Intervention: Drug: Sublingual film containing Igalmi Sponsors: BioXcel Therapeutics Inc; Lotus Clinical Research, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Antipsychotic Induced Hyperprolactinemaia as Risk Factor for Periodontitis in Schizophrenic Patients
Conditions: Schizophrenia Spectrum and Other Psychotic Disorders; Periodontal Diseases Intervention: Drug: antipsychotic drugs inducing hyperprolactinemia Sponsor: Fayoum University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder
Conditions: Bipolar Disorder; Schizophrenia; Agitation,Psychomotor; Schizo Affective Disorder; Schizophreniform Disorders Intervention: Drug: Sublingual film containing Igalmi Sponsors: BioXcel Therapeutics Inc; Lotus Clinical Research, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Antipsychotic Induced Hyperprolactinemaia as Risk Factor for Periodontitis in Schizophrenic Patients
Conditions: Schizophrenia Spectrum and Other Psychotic Disorders; Periodontal Diseases Intervention: Drug: antipsychotic drugs inducing hyperprolactinemia Sponsor: Fayoum University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder
Conditions: Bipolar Disorder; Schizophrenia; Agitation,Psychomotor; Schizo Affective Disorder; Schizophreniform Disorders Intervention: Drug: Sublingual film containing Igalmi Sponsors: BioXcel Therapeutics Inc; Lotus Clinical Research, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Antipsychotic Induced Hyperprolactinemaia as Risk Factor for Periodontitis in Schizophrenic Patients
Conditions: Schizophrenia Spectrum and Other Psychotic Disorders; Periodontal Diseases Intervention: Drug: antipsychotic drugs inducing hyperprolactinemia Sponsor: Fayoum University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder
Conditions: Bipolar Disorder; Schizophrenia; Agitation,Psychomotor; Schizo Affective Disorder; Schizophreniform Disorders Intervention: Drug: Sublingual film containing Igalmi Sponsors: BioXcel Therapeutics Inc; Lotus Clinical Research, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Antipsychotic Induced Hyperprolactinemaia as Risk Factor for Periodontitis in Schizophrenic Patients
Conditions: Schizophrenia Spectrum and Other Psychotic Disorders; Periodontal Diseases Intervention: Drug: antipsychotic drugs inducing hyperprolactinemia Sponsor: Fayoum University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder
Conditions: Bipolar Disorder; Schizophrenia; Agitation,Psychomotor; Schizo Affective Disorder; Schizophreniform Disorders Intervention: Drug: Sublingual film containing Igalmi Sponsors: BioXcel Therapeutics Inc; Lotus Clinical Research, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Antipsychotic Induced Hyperprolactinemaia as Risk Factor for Periodontitis in Schizophrenic Patients
Conditions: Schizophrenia Spectrum and Other Psychotic Disorders; Periodontal Diseases Intervention: Drug: antipsychotic drugs inducing hyperprolactinemia Sponsor: Fayoum University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder
Conditions: Agitation Associated With Schizophrenia or Bipolar Disorder; Bipolar Disorder; Schizophrenia; Agitation,Psychomotor Intervention: Drug: Sublingual film containing Igalmi Sponsors: BioXcel Therapeutics Inc; Lotus Clinical Research, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Antipsychotic Induced Hyperprolactinemaia as Risk Factor for Periodontitis in Schizophrenic Patients
Conditions: Schizophrenia Spectrum and Other Psychotic Disorders; Periodontal Diseases Intervention: Drug: antipsychotic drugs inducing hyperprolactinemia Sponsor: Fayoum University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Effect of Immersive Virtual Reality-based Cognitive Remediation in Patients With Mood - or Psychosis Spectrum Disorders
Conditions: Bipolar Disorder; Depression; Psychotic Disorders; Cognitive Impairment; Schizophrenia; Schizotypal Disorder Interventions: Behavioral: Virtual reality Based Cognitive Remediation; Behavioral: Virtual reality control training Sponsors: Mental Health Services in the Capital Region, Denmark; TrygFonden, Denmark; University of Copenhagen; Rigshospitalet, Denmark Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2023 Category: Research Source Type: clinical trials
